A carregar...

Influence of Competing Risks on Estimating the Expected Benefit of Warfarin Among Atrial Fibrillation Patients not Currently Taking Anticoagulants: the ATRIA Study

BACKGROUND/OBJECTIVES: To date, studies examining the association between warfarin therapy and incidence of ischemic stroke among patients with atrial fibrillation (AF) have not accounted for the competing risk of death. Competing risk analysis may provide greater understanding of the “real world” i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Geriatr Soc
Main Authors: Ashburner, Jeffrey M., Go, Alan S., Chang, Yuchiao, Fang, Margaret C., Fredman, Lisa, Applebaum, Katie M., Singer, Daniel E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5258686/
https://ncbi.nlm.nih.gov/pubmed/27861698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.14516
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!